Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population

New England Journal of Medicine

Volumn 333, Issue 20, 1995, Pages 1308-1312

  Miettinen, Tatu A ^a   Puska, Pekka ^b   Gylling, Helena ^a   Vanhanen, Hannu ^a   Vartiainen, Erkki ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; MARGARINE; SITOSTANOL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIET THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; HYPOCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; DIETARY FATS; DOUBLE-BLIND METHOD; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, HDL CHOLESTEROL; LIPOPROTEINS, LDL CHOLESTEROL; MALE; MARGARINE; MIDDLE AGE; SITOSTEROLS; TRIGLYCERIDES;

EID: 0028822216     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199511163332002     Document Type: Article

References (23)

1. Miettinen TA, Tilvis RS, Kesaniemi YA Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 1990; 131: 20-31
2. Farquhar JW, Smith RE, Dempsey ME The effect of beta sitosterol on the serum lipids of young men with arteriosclerotic heart disease. Circulation 1956; 14: 77-82
3. Lees RS, Lees AM. Effects of sitosterol therapy on plasma lipid and lipoprotein concentrations. In: Greten H, ed. Lipoprotein metabolism. Berlin, Germany: Springer-Verlag, 1976:119-24.
4. Lees AM, Mok HYI, Lees RS, McCluskey MA, Grundy SM Plant sterols as cholesterol-lowering agents: clinical trials in patients with hypercholesterolemia and studies of sterol balance. Atherosclerosis 1977; 28: 325-338
5. Schwartzkopff W, Jantke H-J Dosiswirksamkeit von β-Sitosterin bei Hypercholesterinä mien der Typen IIa und IIb. MMW Munch Med Wochenschr 1978; 120: 1575-1578
6. Oster P, Schlierf G, Heuck CC, Sitosterin bei familiä rer Hyperlipoproteinä mie Typ II: eine randomisierte gekreuzte Doppelblindstudie. Dtsch Med Wochenschr 1976; 101: 1308-1311
7. Grundy SM, Ahrens EH Jr, Davignon J The interaction of cholesterol absorption and cholesterol synthesis in man. J Lipid Res 1969; 10: 304-315
8. Heinemann T, Leiss O, von Bergmann K Effect of low-dose sitostanol on serum cholesterol in patients with hypercholesterolemia. Atherosclerosis 1986; 61: 219-223
9. Heinemann T, Kullak-Ublick G-A, Pietruck B, von Bergmann K Mechanisms of action of plant sterols on inhibition of cholesterol absorption: comparison of sitosterol and sitostanol. Eur J Clin Pharmacol 1991; 40: Suppl 1: S59-S63
10. Becker M, Staab D, von Bergmann K Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol. J Pediatr 1993; 122: 292-296
11. Vanhanen HT, Blomqvist S, Ehnholm C, Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment. J Lipid Res 1993; 34: 1535-1544
12. Miettinen TA, Vanhanen H Dietary sitostanol related to absorption, synthesis and serum level of cholesterol in different apolipoprotein E phenotypes. Atherosclerosis 1994; 105: 217-226
13. Gylling H, Miettinen TA Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia 1994; 37: 773-780
14. Vanhanen HT, Kajander J, Lehtovirta H, Miettinen TA Serum levels, absorption efficiency, faecal elimination and synthesis of cholesterol during increasing doses of dietary sitostanol esters in hypercholesterolaemic subjects. Clin Sci 1994; 87: 61-67
15. Vartiainen E, Puska P, Jousilahti P, Korhonen HJ, Tuomilehto J, Nissinen A Twenty-year trends in coronary risk factors in North Karelia and in other areas of Finland. Int J Epidemiol 1994; 23: 495-504
16. Friedewald WT, Levy RI, Fredrickson DS Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
17. Tilvis RS, Miettinen TA Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 1986; 43: 92-97
18. Miettinen TA, Koivisto P. Non-cholesterol sterols and bile acid production in hypercholesterolaemic patients with ileal bypass. In: Paumgartner G, Stiehl A, Gerok W, eds. Bile acids and cholesterol in health and disease. Boston: MTP Press, 1983:183-7.
19. Gardner MJ, Altman DG Confidence intervals rather than P values: estimation rather than hypothesis testing. BMJ 1986; 292: 746-750
20. Law MR, Wald NJ, Thompson SG By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994; 308: 367-372
21. Mattson FH, Grundy SM, Crouse JR Optimizing the effect of plant sterols on cholesterol absorption in man. Am J Clin Nutr 1982; 35: 697-700
22. Denke MA Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia. Am J Clin Nutr 1995; 61: 392-396
23. Witztum JL, Steinberg D Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-1792